TGTX — TG Therapeutics, Inc.

TGTXTG Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · tgtherapeutics.com

39.63USD+1.96%Mkt Cap: 6.10B USDP/E: 13.94Last update: 2026-05-26

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationall…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap6.10B USD

Enterprise Value5.80B USD

Revenue (TTM)700.35M USD

Gross Profit515.57M USD

Net Income (TTM)447.18M USD

Revenue/Share4.872 USD

Last Price39.63 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees399

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)13.94

P/E (Forward)14.38

PEG1.61

EV/EBITDA38.78

EV/Revenue8.28

P/S8.58

P/B8.68

EPS (TTM)2.86

EPS (Forward)2.73

52W Range

25.2874% of range44.65

52W High44.65 USD

52W Low25.28 USD

Profitability

Gross Margin83.66%

Oper. Margin16.98%

EBITDA Margin21.36%

Profit Margin72.56%

ROE69.01%

ROA42.06%

Growth

Revenue Growth69.60%

Earnings Growth300.00%

Cash Flow & Leverage

Operating CF-24.77M USD

CapEx (TTM)214.00K USD

FCF Margin-4.31%

FCF Yield-0.49%

Net Debt239.13M USD

Net Debt/EBITDA1.60

Balance Sheet

Debt/Equity0.39

Current Ratio5.81

Quick Ratio4.84

Book Value/Sh4.522 USD

Cash/Share3.630 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split100:5625

Split DateApr 30, 2012

Analyst Consensus

Rating1.7 (Buy)

Target (Mean)48.00 USD

Target Range17.00 USD – 70.00 USD

# Analysts7

Ownership

Shares Out.153.08M

Float135.10M

Insiders7.47%

Institutions70.32%

Short Interest

Short Ratio14.9d

Short % Float25.51%

Short % Out.17.65%

Shares Short27.03M

Short (prev mo.)28.94M

Technical

SMA 5035.17 (+12.7%)

SMA 20032.21 (+23.0%)

Beta1.68

S&P 52W Chg28.31%

Avg Vol (30d)2.08M

Avg Vol (10d)1.95M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—